SwiftCare Billing celebrates its fifth anniversary as a leading medical billing and revenue cycle management provider in New Jersey and across the U.S.
MARLTON, N.J., Aug. 25, 2025 /PRNewswire/ — SwiftCare Billing, a Marlton, New Jersey, medical billing and revenue cycle management firm, celebrated its fifth anniversary.
Over the past five years, SwiftCare billing has expanded to support more than 150 medical specialties nationwide and achieved an industry-leading performance, including a 98% claims acceptance rate on first submissions.
These milestones have helped earn SwiftCare recognition as a top-billing provider in the Camden, NJ, region.
Since its launch, the company has delivered strong growth and proven results for its healthcare clients.
Key accomplishments include:
Ghazanfar Bashir (CEO) underscored the company’s mission and future focus:
“SwiftCare Billing has grown stronger through every challenge, proving our resilience during the pandemic and beyond. We continue to evolve with one focus — delivering reliable, precise billing solutions. Our commitment to clients remains the foundation of everything we do.”
To learn more about SwiftCare Billing’s services and success stories, visit https://swiftcarebilling.com/.
About SwiftCare Billing
Founded in 2020 and headquartered in Marlton, NJ, SwiftCare Billing provides end-to-end medical billing and revenue cycle management services for healthcare providers across the United States. The company’s experienced team handles claims submission, coding, credentialing, billing follow-up, and denials management, helping organizations increase revenue and reduce administrative burdens.
Media Contact
Ghazanfar Bashir
(848) 359-5702
ghazanfar.bashir@swiftcarebilling.com
https://swiftcarebilling.com/
SOURCE SwiftCare Billing
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…
This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…
KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…
LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…